The market for bio-process is expected to grow at a higher CAGR during the forecast period
For best outcomes, most patients undergo 48 sessions, spaced weekly or bi-weekly
This is consistent with the known side effect profile of GLP-1 medications, where headaches appear in a meaningful minority of patients during dose initiation and escalation phases
Tirzepatide, sold as Mounjaro, is a dual-action medication that targets both GLP-1 and another hormone called GIP
FIGURE 4 4 Comparative overview of mainstream GLP-1RAs Over the past 2 decades, several GLP-1RAs have entered clinical practice, including short-acting exenatide, intermediate-acting liraglutide, and long-acting formulations such as dulaglutide and semaglutide, as well as the newer dual agonist tirzepatide